Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hrbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Diabetes: metformin + one other agent for 90 days each Weight loss: 6-month lifestyle program + trial of phentermine or orlistat If yes: 65% approval probability on first PA submission If no: 12% approval probability, expect step-therapy denial This framework correctly predicts coverage outcome in 84% of cases based on our patient intake data patterns
Researchers are starting to look into a potential link between GLP-1 medications and changes in perception, especially in the areas of taste and smell
Leggere attentamente le indicazioni riportate in etichetta